Naproxen sodium is a small molecule that works as a Cyclooxygenase Inhibitor.[2] It is being investigated across 15 indications, with its most advanced program in Preclinical.[1]
Naproxen sodium is one of 205 small molecule programs targeting Contraception. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
176 competitors in Rheumatoid Arthritis
Actos
Naproxen sodium
Celexa
Voltaren
Cataflam
Plaquenil
Vibramycin
Velcade
Vancocin
Disalcid
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources